{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:25Z","timestamp":1791895585448,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jaad.2020.12.071","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:51:34Z","timestamp":1610355094000},"page":"1348-1355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Long-term use of spironolactone for acne in women: A case series of 403 patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Vaibhav","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana K.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2020.12.071_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.071_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","article-title":"Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments","volume":"80","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): a retrospective cohort study","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.071_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.12.071_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2015.01.048","article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings","volume":"72","author":"Straight","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.071_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.071_bib7","article-title":"Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris","author":"Guzman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib8","first-page":"30","article-title":"Patient awareness of antimicrobial resistance and antibiotic use in acne vulgaris","volume":"12","author":"Del Rosso","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2020.12.071_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000471799","article-title":"Spironolactone for the treatment of acne: a 4-year retrospective study","volume":"233","author":"Grandhi","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.12.071_bib10","article-title":"High-dose spironolactone for acne in patients with polycystic ovarian syndrome: a single institution retrospective study","author":"Basu","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.12.071_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijwd.2016.12.002","article-title":"Spironolactone for the treatment of acne in women, a retrospective study of 110 patients","volume":"3","author":"Charny","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2020.12.071_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/jdv.16302","article-title":"Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017","volume":"34","author":"Roberts","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00266-006-0081-0","article-title":"Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians","volume":"30","author":"Sato","year":"2006","journal-title":"Aesthet Plast Surg"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.12.071_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1684\/ejd.2017.3062","article-title":"Adult female acne treated with spironolactone: a retrospective data review of 70 cases","volume":"27","author":"Isvy-Joubert","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40257-018-0349-6","article-title":"The use of hormonal antiandrogen therapy in female patients with acne: a 10-year retrospective study","volume":"19","author":"Park","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/120347540200600604","article-title":"Long-term safety of spironolactone in acne: results of an 8-year followup study","volume":"6","author":"Shaw","year":"2002","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaad.2019.03.036","article-title":"Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne","volume":"81","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib19","first-page":"632","article-title":"Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2310\/7750.2007.00037","article-title":"Development and validation of a comprehensive acne severity scale","volume":"11","author":"Tan","year":"2007","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.jaad.2020.12.071_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.jaad.2020.12.071_bib22","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1111\/jdv.16634","article-title":"Truncal acne, what do we know?","volume":"34","author":"Poli","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/dth.12231","article-title":"Management of acne vulgaris with hormonal therapies in adult female patients","volume":"28","author":"Husein-ElAhmed","year":"2015","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2020.12.071_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris","volume":"71","author":"Koo","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.12.071_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamadermatol.2018.4944","article-title":"Trends in oral antibiotic prescription in dermatology, 2008 to 2016","volume":"155","author":"Barbieri","year":"2019","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:14Z","timestamp":1759273154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0190962221000906"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.071","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term use of spironolactone for acne in women: A case series of 403 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}